Cargando…
Revisiting the use of graph centrality models in biological pathway analysis
The use of graph theory models is widespread in biological pathway analyses as it is often desired to evaluate the position of genes and proteins in their interaction networks of the biological systems. In this article, we argue that the common standard graph centrality measures do not sufficiently...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296696/ https://www.ncbi.nlm.nih.gov/pubmed/32549913 http://dx.doi.org/10.1186/s13040-020-00214-x |
_version_ | 1783546884750573568 |
---|---|
author | Naderi Yeganeh, Pourya Richardson, Chrsitine Saule, Erik Loraine, Ann Taghi Mostafavi, M. |
author_facet | Naderi Yeganeh, Pourya Richardson, Chrsitine Saule, Erik Loraine, Ann Taghi Mostafavi, M. |
author_sort | Naderi Yeganeh, Pourya |
collection | PubMed |
description | The use of graph theory models is widespread in biological pathway analyses as it is often desired to evaluate the position of genes and proteins in their interaction networks of the biological systems. In this article, we argue that the common standard graph centrality measures do not sufficiently capture the informative topological organizations of the pathways, and thus, limit the biological inference. While key pathway elements may appear both upstream and downstream in pathways, standard directed graph centralities attribute significant topological importance to the upstream elements and evaluate the downstream elements as having no importance.We present a directed graph framework, Source/Sink Centrality (SSC), to address the limitations of standard models. SSC separately measures the importance of a node in the upstream and the downstream of a pathway, as a sender and a receiver of biological signals, and combines the two terms for evaluating the centrality. To validate SSC, we evaluate the topological position of known human cancer genes and mouse lethal genes in their respective KEGG annotated pathways and show that SSC-derived centralities provide an effective framework for associating higher positional importance to the genes with higher importance from a priori knowledge. While the presented work challenges some of the modeling assumptions in the common pathway analyses, it provides a straight-forward methodology to extend the existing models. The SSC extensions can result in more informative topological description of pathways, and thus, more informative biological inference. |
format | Online Article Text |
id | pubmed-7296696 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-72966962020-06-16 Revisiting the use of graph centrality models in biological pathway analysis Naderi Yeganeh, Pourya Richardson, Chrsitine Saule, Erik Loraine, Ann Taghi Mostafavi, M. BioData Min Research The use of graph theory models is widespread in biological pathway analyses as it is often desired to evaluate the position of genes and proteins in their interaction networks of the biological systems. In this article, we argue that the common standard graph centrality measures do not sufficiently capture the informative topological organizations of the pathways, and thus, limit the biological inference. While key pathway elements may appear both upstream and downstream in pathways, standard directed graph centralities attribute significant topological importance to the upstream elements and evaluate the downstream elements as having no importance.We present a directed graph framework, Source/Sink Centrality (SSC), to address the limitations of standard models. SSC separately measures the importance of a node in the upstream and the downstream of a pathway, as a sender and a receiver of biological signals, and combines the two terms for evaluating the centrality. To validate SSC, we evaluate the topological position of known human cancer genes and mouse lethal genes in their respective KEGG annotated pathways and show that SSC-derived centralities provide an effective framework for associating higher positional importance to the genes with higher importance from a priori knowledge. While the presented work challenges some of the modeling assumptions in the common pathway analyses, it provides a straight-forward methodology to extend the existing models. The SSC extensions can result in more informative topological description of pathways, and thus, more informative biological inference. BioMed Central 2020-06-16 /pmc/articles/PMC7296696/ /pubmed/32549913 http://dx.doi.org/10.1186/s13040-020-00214-x Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Naderi Yeganeh, Pourya Richardson, Chrsitine Saule, Erik Loraine, Ann Taghi Mostafavi, M. Revisiting the use of graph centrality models in biological pathway analysis |
title | Revisiting the use of graph centrality models in biological pathway analysis |
title_full | Revisiting the use of graph centrality models in biological pathway analysis |
title_fullStr | Revisiting the use of graph centrality models in biological pathway analysis |
title_full_unstemmed | Revisiting the use of graph centrality models in biological pathway analysis |
title_short | Revisiting the use of graph centrality models in biological pathway analysis |
title_sort | revisiting the use of graph centrality models in biological pathway analysis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296696/ https://www.ncbi.nlm.nih.gov/pubmed/32549913 http://dx.doi.org/10.1186/s13040-020-00214-x |
work_keys_str_mv | AT naderiyeganehpourya revisitingtheuseofgraphcentralitymodelsinbiologicalpathwayanalysis AT richardsonchrsitine revisitingtheuseofgraphcentralitymodelsinbiologicalpathwayanalysis AT sauleerik revisitingtheuseofgraphcentralitymodelsinbiologicalpathwayanalysis AT loraineann revisitingtheuseofgraphcentralitymodelsinbiologicalpathwayanalysis AT taghimostafavim revisitingtheuseofgraphcentralitymodelsinbiologicalpathwayanalysis |